Results 161 to 170 of about 72,965 (197)

Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial

Lancet, The, 2020
Kwok-Cheung Lung, Tom Wai-Hin Chung, Hoi-Ping Shum   +2 more
exaly  

Beta Carotene Preparation

2021
openaire   +1 more source

NEUTROPENIA AND BETA-CAROTENE

The Lancet, 1982
openaire   +2 more sources

Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN)

Lancet, The, 2002
Mauro Bergui
exaly  

Targeted Elimination of Senescent Beta Cells Prevents Type 1 Diabetes

Cell Metabolism, 2019
Peter J Thompson, Vasilis Ntranos, Mark A Atkinson   +2 more
exaly  

Beta Carotene Capsules

2021
openaire   +1 more source

Neutrino–nuclear responses for astro-neutrinos, single beta decays and double beta decays

Physics Reports, 2019
Jouni Suhonen, Kai Zuber
exaly  

Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis

New England Journal of Medicine, 2006
Bianca Weinstock-Guttman
exaly  

Determination of Beta-Carotene and Neo-Beta-Carotene with Visual Spectrophotometer

Industrial & Engineering Chemistry Analytical Edition, 1942
F Zscheile, B Beadle
openaire   +1 more source

Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis

Lancet, The, 2003
Per Soelberg Sørensen, Thor Petersen, Egon Stenager   +2 more
exaly